Probable disseminated BCG infection in a 10-month-old child after BCG vaccination

Ahmed Zaïem1, Senda El Ferjani, Ghozlane Lakhoua

  • 1a National Center of Pharmacovigilance; Tunis, Tunisia.

Insights

Disseminated bacillus Calmette-Guerin (BCG) infection is a rare complication. This case highlights a 10-month-old child

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Bacillus Calmette-Guerin (BCG) vaccination is widely used to prevent tuberculosis.
  • Disseminated BCG infection is a rare but severe adverse event following vaccination.
  • Early identification and management are crucial for favorable outcomes.

Observation:

  • A 10-month-old infant vaccinated at birth developed recurrent lymphadenopathy at 40 days and 6 months.
  • Cutaneous ulcerative lesions appeared weeks after the second lymphadenopathy episode.
  • Radiographic imaging revealed osteolysis in the left middle finger.

Findings:

  • Skin biopsy confirmed lesions compatible with tuberculosis.
  • The clinical presentation and diagnostic findings suggest probable disseminated BCG infection.
  • The infant was treated with anti-tuberculosis antibiotics.

Implications:

  • This case underscores the importance of vigilance for disseminated BCG infection in infants presenting with persistent or recurrent lymphadenopathy and systemic symptoms.
  • Prompt diagnosis and appropriate anti-tuberculosis therapy are essential for managing this rare vaccine complication.
  • Further research into risk factors and optimal management strategies for disseminated BCG infection is warranted.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
73
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
768
Vaccinations01:51

Vaccinations

Overview
54.7K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.7K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.6K